• 1
    Frisk G, Torfason E, Diderholm H. Reserve radioimmunoassays of IgM and IgG antibodies to Coxsackie B viruses in patients with acute perimyocarditis. J Med Virol 1984; 14:191200.
  • 2
    Vikerfors T, Stjerna A, Olcen P, Malmcrona R, Magnius L. Acute myocarditis: serologic diagnosis, clinical findings and follow-up. Acta Med Scand 1988; 223:4553.
  • 3
    Woodruff JF. Viral myocarditis. A review. Am J Pathol 1980; 101:42584.
  • 4
    Shabetai R. Myocarditis and dilated cardiomyopathy: twins or distant relatives? Cardiology 1989; 76:3327.
  • 5
    Archard LC, Bowles NE, Olsen EGJ, Richardson PJ. Detection of coxsackie B virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis in dilated cardiomyopathy. Lancet 1986;1120.
  • 6
    Hohenadl C, Klingel K, Mertsching J, Hofschneider PH, Kandolf R. Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Molecular and Cellular Probes 1991; 5:1120.
  • 7
    Nettelbladt O, Tengblad A, Hällgren R. Accumulation of hyaluronan/hyaluronic acid in lung tissue during experimental alveolitis parallels development of interstitial edema. Am J Physiol: Lung Cellular Molecul 1989; 257:37984.
  • 8
    Hällgren R, Gerdin B, Tengblad B, Tufveson, G. Accumulation of hyaluronan (hyaluronic acid) in myocardial intersitial tissue parallels development of transplantation edema in heart allo-grafts in rats. J Clin Invest 1990; 85:66873.
  • 9
    Hällgren R, Gerdin B, Tufveson G. Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft: relationship to the transplantation edema. J Exp Med 1990; 171:206376.
  • 10
    Waldenström A, Martinussen HJ, Gerdin B, Hällgren R. Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J Clin Invest 1991; 88:16228.
  • 11
    Ldurent TC. Structure of hyaluronic acid. In: BalazsEA, ed. Chemistry and Molecular Biology of the intercellular matrix. New York and London : Academic Press 1970:32333.
  • 12
    Mason RM. Recent advances in the biochemistry of hyaluronic acid in cartilage. Progr Clin Biol Res 1981; 54:87112.
  • 13
    Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev 1978; 58:255315.
  • 14
    Tengblad A. Quantitative analysis of hyaluronate in nanogram amounts. Biochem J 1980; 185:1015.
  • 15
    Brandt R, Hedlöf E, Åsman I, Bucht A, Tengblad A. A convenient radiometric assay for hyaluronan. Acta Oto-laryngologica. Supplement 1986; 442:315.
  • 16
    Hascell VC. Interaction of cartilage proteoglycans with hyaluronic acid. J Supramol Struct 1977; 7:10120.
  • 17
    Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the islation of hyaluronate binding proteins from cartilage. Biochem Biophys Acta 1979; 578:2819.
  • 18
    Ripellino JA, Klinger MM, Margolis RU, Margolis RK. The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue sections. J Histochem Cytochem 1985; 33:10606.
  • 19
    Hultman J, Ronquist G. Myocardial high energy phosphates and function under different postischemic conditions. Eur Surg Res 1984; 16:20113.
  • 20
    Atkinson DE. Energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 1968; 7:40304.
  • 21
    Lebel L, Smith L, Risberg B, Gerdin B, Laurent TC. Effect of increased hydrostatic pressure on lymphatic elimination of hyaluronan from sheep lung. J Appl Physiol 1988; 64:132732.
  • 22
    Reed RK, Townsley MI, Laurent TC, Taylor AE. Hyaluronan flux from cat intestine: changes with lymph flow. Am J Physiol 1992; 262: H45762.
  • 23
    Reed RK, Laurent TC, Taylor AE. Hyaluronan in prenodal lymph from skin: changes with lymph flow. Am J Physiol 1990; 259:H1097100.
  • 24
    Johnsson RL, Ziff M. Lymphokine stimulation of collagen accumulation. J Clin Invest 1976; 58:2408.
  • 25
    Wahl SM, McCarthy JB. Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol. 1978; 121:9426.
  • 26
    Hamerman D, Wood DD. Interleukin 1 enhances synovial cell hyaluronate synthesis. Proc Soc Exp Biol Med 1984; 177:20510.
  • 27
    Engström-Laurent A, Feltelius N, Hällgren R, Wasteson P. Elevated serum hyaluronate in scleroderma. An effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis 1985; 44:61420.
  • 28
    Rovetto MJ. Effect of hyaluronidase and methylprednisolone on myocardial function, glucose metabolism and coronary flow in the isolated ischemic rat heart. Circul Res 1977; 41:3739.
  • 29
    Maroko PR, Davidson DM, Libby P, Hagan AD, Braunwald E. Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation 1972; 46:4307.
  • 30
    Maclean D, Fishbein MC, Maroko PR, Braunwald E. Hyaluro-nidase-induced reduction in myocardial infarct size. Science 1976; 194:199200.
  • 31
    Roberts R, Braunwald E, Muller JE et al. Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatinine kinase MB and non-transmural ischaemia. Br Heart J 1988; 60:2908.
  • 32
    Martins de Oliveira J, Carballo R, Zimmerman HA. Intravenous injection of hyaluronidase in acute myocardial infarction; preliminary report of clinical and experimental observations. Am Heart J 1959; 57:71222.
  • 33
    Sunnergren KP, Rovetto MJ. The effects of hyaluronidase on interstitial hydration, plasma protein exclusion, and microvascu-lar permeability in the isolated perfused rat heart. Microvas Res 1985; 30:28697.
  • 34
    Ilbäck NG, Wesslén L, Pauksen K, Stålhandske T, Friman G, Fohlman J. Effects of the anti-viral WIN 54954 and the immune modulator LS 2616 on chachectin/TNF and γ-interferon responses during viral heart disease. Scand J Inf Dis 1993; suppl 88:111723.
  • 35
    Tracy S, Chapman N., Beck MA. Molecular biology and pathogenesis of coxsackie B viruses. Rev Med Virol: in press.
  • 36
    Beisel KW, Wolfgram IJ, Herskowitz A, Rose NR. Differences in severity of coxsackievirus B3–induced myocarditis among H-2 congenic mouse strains. Genetic control of resistance to infection and malignancy. Skamene ed. New York : Alan R Liss, 1985.
  • 37
    Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983; 52:10728.
  • 38
    Maisch B, Trostel-Soeder R, Stechemesser E, Berg PA, Kochsiek K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol 1982; 48:53345.
  • 39
    Huber SA, Simpson K, Weller A, Herzum M. Immunopathoge-nic mechanisms in experimental myocarditis: evidence for autoimmunity to the virus receptor and antigenic mimicry between virus and cardiocyte. New concepts in viral heart disease. Schultheiss ed. Berlin : Springer-Verlag, 1988.
  • 40
    Weller, A, Simpson K, Herzum M, van Houten N, Huber SA. Coxsackievirus-B3–induced myocarditis: virus receptor antibodies modulate myocarditis. J Immunol 1989; 143:184350.
  • 41
    Alvarez FL, Neu N, Rose NR, Craig SW, Beisel KW. Heart-specific autoantibodies induced by coxsackievirus B3: Identification of heart autoantigens. Clin Immunol Immunopathol 1987; 43:12939.
  • 42
    Rose NR, Neu N, Neumann DA, Herskowitz A. Myocarditis: a postinfectious autoimmune disease. New concepts in viral heart disease. Schultheiss ed. Berlin : Springer-Verlag, 1988.
  • 43
    Gauntt CJ, Arizpe HM, Higdon AL, Rozek MM, Crawley R, Cunhingham MW. Anti-Coxsackievirus 83 neutralizing antibodies with pathological potential. Eur Heart J (Supplement D) 1991; 12:1249.
  • 44
    Lpdge PA, Herzum M, Olszewski J, Huber SA. Coxsackievirus B3 myocarditis. Acute and chronic forms of the disease caused by different immunopathologic mechanisms. Am J Pathol 1987; 128:145563.
  • 45
    van Houton N, Huber S. Role of cytotoxic T cells in experimental myocarditis. Springer Sem Immunopathol 1989; 11:618.
  • 46
    Fohlman J, Friman G, Ilbäck NG, Åkesson Å, Huber S. A qualitative and quantitative method for in situ characterization of the inflammatory response in experimental myocarditis. APMIS 1990; 98:55967.
  • 47
    Fozzard HA. Conduction of the action potential. In: BerneRM, SperelakisN, GeigerSR, eds. Handbook of physiology. section 2: the cardiovascular system. volume 1. The Heart. Bethesda , Maryland : American Psychological Society, 1979: 33856.